Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer

British Journal of Cancer

Volumn 80, Issue 12, 1999, Pages 1935-1944

  Coulson, J M ^a   Stanley, J ^a   Woll, P J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Enhancer; Promoter; SCLC; Transcription; Tumour specific; Vasopressin

Indexed keywords

ARGIPRESSIN; DNA FRAGMENT; TRANSCRIPTION FACTOR;

ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; GENE ACTIVATION; GENE MAPPING; GENE TARGETING; GENE THERAPY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; REPORTER GENE;

ARGININE VASOPRESSIN; CARCINOMA, SMALL CELL; CHLORAMPHENICOL O-ACETYLTRANSFERASE; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; HYPOTHALAMUS; LUNG NEOPLASMS; PROMOTER REGIONS (GENETICS); RESTRICTION MAPPING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032802285     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690623     Document Type: Article

References (37)

1. Ang HL, Carter DA and Murphy D (1993) Neuron-specific expression and physiological regulation of bovine vasopressin transgenes in mice. EMBO J 12: 2397-2409
2. Bahnsen U, Oosting P, Swaab DF, Nahke P, Richter D and Schmale H (1992) A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophyseal diabetes insipidus. EMBO J 11: 10-23
3. Ball DW, Azzoli CG, Baylin SB, Chi D, Dou S, Donis-Keller H, Cumaraswamy A, Borges M and Nelkin BD (1993) Identification of a human achaete-scule homolog highly expressed in neuroendocrine tumours. Proc Natl Acad Sci USA 90: 5648-5652
4. Baum C, Forster P, Hegewisch-Becker S and Harbers S (1994) An optimised electroporation protocol applicable to a wide range of cell lines. Biotechniques 17: 1058-1062
5. Burke ZD, Ho MY, Morgan H, Smith M, Murphy D and Carter D (1997) Repression of vasopressin gene expression by glucocorticoids in transgenic mice: evidence of a direct mechanism mediated by proximal 5′ flanking sequence. Neuroscience 78: 1177-1185
6. Coulson JM, Stanley J, Staff D and Woll PJ (1997) Evaluation of AVP and V1a receptor expression in SCLC cell lines: potential for an autocrine growth loop? Lung Cancer 18: A599
7. Fay MJ, Friedmann AS, Yu XM and North WG (1994) Vasopressin and vasopressin-receptor immunoreactivity in small-cell lung carcinoma (SCCL) cell lines disruption in the activation cascade of V-1a receptors in variant SCCL. Cancer Lett 82: 167-174
8. Fiering SN, Roederer M, Nolan GP, Micklem DR, Parks DR and Herzenberg LA (1991) Improved FACS-Gal: flow cytometric analysis and sorting of viable eukaryotic cells expressing reporter gene constructs. Cytometry 12: 291-301
9. Friedmann AS, Memoli VA and North WG (1993) Vasopressin and oxytocin production by non-neuroendocrine lung carcinomas; an apparent low incidence of gene expression. Cancer Lett 75: 79-85
10. Friedmann AS, Mallot KA, Memoli VA, Pai SJ, Yu X-M and North WG (1994) Products of vasopressin gene expression in small-cell carcinoma of the lung. Br J Cancer 69: 260-263
11. Grace CO, Fink G and Quinn JP (1999) Characterization of potential regulatory elements within the rat arginine vasopressin proximal promoter. Neuropeptides 33: 81-90
12. Gross AJ, Steinberg SM, Reilly JG, Bliss DP, Brennan J, Le PT, Simmons A, Phelps R, Mulshine JL, Ihde DC and Johnson BE (1993) Atrial natriuretic factor and arginine vasopressin production in tumour cell lines from patients with lung cancer and their relationship to serum sodium. Cancer Res 53: 67-74
13. Hara Y, Battey J and Gainer H (1990) Structure of the mouse vasopressin and oxytocin genes. Mol Brain Res 8: 319-324
14. Huber BE, Richards CA and Krenitsky TA (1991) Retroviral mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc Natl Acad Sci USA 88: 8039-8043
15. Iwasaki I, Oiso Y, Saito H and Majzoub JA (1997) Positive and negative regulation of the rat vasopressin gene promoter. Endocrinology 138: 5266-5274
16. Jin X, Shearman LP, Weaver DR, Zylka MJ, De Vries GJ and Reppert SM (1999) A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell 96: 57-68
17. Johnson BE, Chute JP, Rushin J, Williams J, Le T, Venzon D and Richardson GE (1997) A prospective study of patients with lung cancer and hyponatremia of malignancy. Am J Respir Crit Care Med 156: 1669-1678
18. Kim JK, Summer SN, Wood WM and Schrier RW (1996) Osmotic and non-osmotic regulation of arginine vasopressin (AVP) release, mRNA, and promoter activity in small cell lung cancer (SCLC) cells. Mol Cell Endocrinol 123: 179-186
19. Kumagai T, Tanio Y, Osaki T, Hosoe S, Tachibana I, Ueno K, Kijima T, Horai Tand Kishimoto T (1996) Eradication of myc-overexpressing small cell lung cancer cells transfected with herpes simplex thymidine kinase gene containing myc max response elements. Cancer Res 56: 354-358
20. Maier JAM, Voulalas P, Roeder D and Macaig T (1990) Extension of the life-span of human endothelial cells by an interleukin 1α antisense oligomer. Science 249: 1570-1574
21. Maurer LH, O'Donell JF, Kennedy S, Faulkner CS, Rist K and North WG (1983) Human neurophysins in carcinoma of the lung: relation to histology, disease stage, response rate, survival, and syndrome of inappropriate antidiuretic hormone secretion. Cancer Treat Rep 67: 971-976
22. Murphy D, Funkhouser J, Ang H-L, Foo NC and Carter D (1993) Extrahypothalamic expression of the vasopressin and oxytocin genes. Ann NY Acad Sci 689: 91-106
23. North WG, Fay MJ, Longo KA and Du J (1998) Expression of all known vasopressin receptor subtypes by small cell tumors implies a multifaceted role for this neuropeptide. Cancer Res 58: 1866-1871
24. Okazaki T, Ishikawa T, Nishimori S, Igarashi T, Hata K and Fujta T (1997) Hyperosmolarity-induced gene stimulation is mediated hy the negative calcium responsive element. J Biol Chem 272: 32274-32279
25. Pardy K, Adah RAH, Carter DA, Seah V, Burbach JPH and Murphy D (1992) The identification of a cis-acting element involved in cyclic 3′, 5′ adenosine monophosphate regulation of bovine vasopressin gene expression. J Biol Chem 267: 21748-21752
26. Pass M, Quintini G, Zarn JA, Zimmermann SM, Sigrist JA and Stahel R (1998). The 5′-flanking region of human CD24 gene has cell-type-specific promoter activity in small-cell lung cancer. Int J Cancer 78: 496-502
27. Prestridge DS (1995) Predicting pol II promoter sequences using transcription factor binding sites. J Mol Biol 249: 923-932
28. Prestridge DS (1996) Signal scan 4.0: new databases and sequence formats. Computer Applications in the Biosciences 12: 157-160
29. Quinn JP (1996) Neuronal-specific gene expression - the interaction of both positive and negative transcriptional regulators. Progress Neurobiol 50. 363-379
30. Sausville E, Carney D and Battey J (1985) The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. J Biol Chem 260: 10236-10241
31. Sethi T and Rozengurt E (1991) Multiple neuropeptides stimulate clonal growth of small cell lung cancer - effects of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin. Cancer Res 51: 3621-3623
32. Terasaki T, Matsuno Y, Shimosato Y, Yamaguchi K, Ichiniose H, Nagatsu T and Kato K (1994) Establishment of a human small cell lung cancer cell line pruducing a large amount of anti-diuretic hormone. Jpn J Cancer Res 85: 718-722
33. Verbeeck MAE, Sutanto W and Burbach JPH (1991) Regulation of vasopressin messenger RNA levels in the small cell lung carcinoma cell line GLC-8: interactions between glucocorticoids and second messengers. Molecular Endocrinology 5: 795-801
34. Verbeeck MAE, Elands JPM, de Leij LFMH, Buys CHCM, Carney DN, Belper G, Roebroeck AJM, Van de Ven WJM and Burbach JPH (1992) Expression of the vasopressin and gastrin-releasing peptide genes in small cell lung carcinoma cell lines. Pathobiol 60: 136-142
35. Vile RG and Hart IR (1993) Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoural injection of DNA. Cancer Res 53: 3860-3864
36. Woll PJ (1996) Growth factors and lung cancer. In: Lung Cancer: Principles and Practice, Pass HI, Mitchell JB, Johnson DH and Turrisi AT (eds), pp. 123-131. Lippincott-Raven: Philadelphia
37. Yoon SO and Chikaraishi DM (1992) Tissue-specific transcription of the rat tyrosine-hydroxylase gene requires synergy between an AP-1 motif and an overlapping E-box containing dyad. Neuron 9: 55-67